Perbak Capital Partners LLP Omnicell, Inc Transaction History
Perbak Capital Partners LLP
- $135 Billion
- Q1 2025
A detailed history of Perbak Capital Partners LLP transactions in Omnicell, Inc stock. As of the latest transaction made, Perbak Capital Partners LLP holds 9,922 shares of OMCL stock, worth $296,072. This represents 0.26% of its overall portfolio holdings.
Number of Shares
9,922Holding current value
$296,072% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding OMCL
# of Institutions
293Shares Held
47MCall Options Held
68KPut Options Held
45.3K-
Black Rock Inc. New York, NY8.18MShares$244 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA2.17MShares$64.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.88MShares$56.2 Million0.02% of portfolio
-
Victory Capital Management Inc1.68MShares$50.1 Million0.06% of portfolio
About OMNICELL, Inc
- Ticker OMCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 44,288,800
- Market Cap $1.32B
- Description
- Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...